AARTIPHARM

Aarti Pharmalabs Share Price

₹619.70 -15.45 (-2.43%)

21 Nov, 2024 14:45

SIP TrendupStart SIP in AARTIPHARM

Start SIP

Performance

  • Low
  • ₹603
  • High
  • ₹640
  • 52 Week Low
  • ₹392
  • 52 Week High
  • ₹722
  • Open Price₹635
  • Previous Close₹635
  • Volume176,443

Investment Returns

  • Over 1 Month + 1.62%
  • Over 3 Month -2.16%
  • Over 6 Month + 0.74%
  • Over 1 Year + 52.97%
SIP Lightning

Smart Investing Starts Here Start SIP with Aarti Pharmalabs for Steady Growth!

Invest Now

Aarti Pharmalabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.6
  • PEG Ratio
  • -1.1
  • Market Cap Cr
  • 5,616
  • P/B Ratio
  • 3.2
  • Average True Range
  • 28.4
  • EPS
  • 25.17
  • Dividend Yield
  • 0.5
  • MACD Signal
  • 6.87
  • RSI
  • 48.71
  • MFI
  • 69.46

Aarti Pharmalabs Financials

Aarti Pharmalabs Technicals

EMA & SMA

Current Price
₹619.70
-15.45 (-2.43%)
pointer
  • stock-down_img
  • Bullish Moving Average 4
  • stock-up_img
  • Bearish Moving Average 12
  • 20 Day
  • ₹642.20
  • 50 Day
  • ₹635.31
  • 100 Day
  • ₹620.89
  • 200 Day
  • ₹580.09

Resistance and Support

639.08 Pivot Speed
  • R3 666.37
  • R2 658.58
  • R1 646.87
  • S1 627.37
  • S2 619.58
  • S3 607.87

What's your outlook on Aarti Pharmalabs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aarti Pharmalabs Ltd. is a leading pharmaceutical company in India, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. It caters to global markets, providing high-quality and innovative solutions for various therapeutic segments.

Aarti Pharmalabs has an operating revenue of Rs. 1,967.98 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 16% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 10% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 65 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 29 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aarti Pharmalabs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-28 Quarterly Results
2024-08-05 Quarterly Results
2024-05-13 Audited Results & Final Dividend
2024-02-07 Quarterly Results & Interim Dividend
2023-11-07 Quarterly Results
Date Purpose Remarks
2024-07-31 FINAL Rs.1.00 per share(20%)Final Dividend
2024-02-19 INTERIM Rs.2.00 per share(40%)Interim Dividend

Aarti Pharmalabs F&O

Aarti Pharmalabs Shareholding Pattern

46.1%
4.93%
6.09%
7.38%
0%
29.45%
6.05%

About Aarti Pharmalabs

  • NSE Symbol
  • AARTIPHARM
  • BSE Symbol
  • 543748
  • Managing Director
  • Mr. Narendra J Salvi
  • ISIN
  • INE0LRU01027

Similar Stocks to Aarti Pharmalabs

Aarti Pharmalabs FAQs

Aarti Pharmalabs share price is ₹619 As on 21 November, 2024 | 14:31

The Market Cap of Aarti Pharmalabs is ₹5616.1 Cr As on 21 November, 2024 | 14:31

The P/E ratio of Aarti Pharmalabs is 24.6 As on 21 November, 2024 | 14:31

The PB ratio of Aarti Pharmalabs is 3.2 As on 21 November, 2024 | 14:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23